Decision 2008/911/EC is amended as follows:
In Annex I, the following substance is inserted after Pimpinella anisum L:
‘Sideritis scardica Griseb., herba.’;
In Annex II, the following is inserted after the COMMUNITY LIST ENTRY on Pimpinella anisum L:
Scientific name of the plant
Sideritis scardica Griseb.
Botanical family
Lamiaceae (Labiatae)
Herbal substance
Ironwort (Sideritis herba)
Common name in all EU official languages of herbal preparation
BG (bălgarski): Мурсалски чай, стрък
CS (čeština): nať hojníku
DA (dansk): Kortkroneurt
DE (Deutsch): Balkan-Gliedkraut
EL (elliniká): Πόα σιδηρίτου
EN (English): Ironwort
ES (español): Siderita, partes aéreas de
ET (eesti keel): haavarohuürt
FI (suomi): raudakki, verso
FR (français): Crapaudine (parties aériennes de)
HR (hrvatska): očistova zelen
HU (magyar): sármányvirág virágos hajtása
IT (italiano): Stregonia parti aeree fiorite
LT (lietuvių kalba): Timsrų žolė
LV (latviešu valoda): Siderītu laksts
MT (Malti): ħaxixa tas-Sideritis
NL (Nederlands): (Griekse) bergthee, kruid
PL (polski): Ziele gojnika
PT (português): Siderite, partes aéreas
RO (română): iarba de ceaiul muntelui cretan
SK (slovenčina): Vňať ránhoja
SL (slovenščina): zel sklepnjaka
SV (svenska): Sårmynta, ört
IS (íslenska):
NO (norsk): Gresk fjellte
Herbal preparations
Comminuted herbal substance
European Pharmacopoeia monograph reference
Not applicable
Indications
Traditional herbal medicinal product used for the relief of cough associated with cold.
Traditional herbal medicinal product used for the relief of mild gastrointestinal discomfort.
The product is a traditional herbal medicinal product for use in specified indications exclusively based upon long-standing use.
Type of tradition
European
Specified strength
Please see “Specified posology”.
Specified posology
Single dose: Herbal tea: 2-4 g of the comminuted herbal substance in 150-200 ml of water as a herbal infusion 2-3 times daily
Daily dose: up to 12 g
The use in children and adolescents under 18 years of age is not recommended (see section “Special warnings and precautions for use”)
Route of administration
Oral use
Duration of use or any restrictions on the duration of use
If symptoms persist longer than 1 week during the use of the medicinal product, a doctor or a qualified health care practitioner should be consulted.
If symptoms persist longer than 2 weeks during the use of the medicinal product, a doctor or a qualified health care practitioner should be consulted.
Any other information necessary for the safe use
Hypersensitivity to the active substance and to other plants of the Lamiaceae (Labiatae) family.
The use in children and adolescents under 18 years of age has not been established due to lack of adequate data.
If the symptoms worsen during the use of the medicinal product, a doctor or a qualified health care practitioner should be consulted.
None reported
Safety during pregnancy and lactation has not been established. In the absence of sufficient data, use during pregnancy and lactation is not recommended.
No fertility data available.
No studies on the effect on the ability to drive and use machines have been performed.
None known
If adverse reactions occur, a doctor or qualified health care practitioner should be consulted.
No case of overdose has been reported.
Not applicable
Not applicable.’